Reports

Ideas That Generate Results

UK Generics Market Analysis

UK Generics Market Analysis

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Apr, 2011| No. of Pages : 55

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 800.00
CD-ROM Mail Delivery
US$ 900.00
Hard Copy Mail Delivery
US$ 900.00
Electronic Access - Multi-User License
US$ 1100.00

List of Figures:

Figure 3-1: Pharmaceutical Market (Billion GBP), 2009 & 2010
Figure 3-2: Forecast for Pharmaceutical Market (Billion GBP), 2011-2013
Figure 3-3: Share of Generics in Pharma Market (%), 2010
Figure 3-4: Forecast for Share of Generics in Pharma Market (%), 2013
Figure 4-1: Population Aged 65 and Above (Million), 2009-2013
Figure 5-1: Generics Market (Billion GBP), 2009-2013
Figure 5-2: Total Number of Prescriptions (Million), 2009-2013
Figure 5-3: Net Ingredient Cost of Prescriptions (Million GBP), 2005-2009
Figure 5-4: Share of Generics Prescriptions in Total Prescriptions (2009)
Figure 5-5: Analgesics Market (Million GBP), 2010 & 2013

List of Tables:

Table 3-1: Healthcare Statistics (2008-2010)
Table 3-2: Forecast for Healthcare Statistics (2011-2013)
Table 4-1: Blockbuster Drugs Going Off-patent (2011-2013)
Table 5-1: Top 10 Most Prescribed Generic Drugs (Million), 2010
Table 7-1: Currently Approved Biosimilar Products in EU
Table 8-1: Teva Pharmaceuticals - SWOT Analysis
Table 8-2: Sandoz - SWOT Analysis
Table 8-3: Actavis UK Ltd. - SWOT Analysis
Table 8-4: Hikma Pharmaceuticals - SWOT Analysis

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.